Being Able to Walk Away | GenomeWeb

"What does it take for a new technology to catch on in the labs?" Derek Lowe asks at In the Pipeline. First, he says that it has to actually be useful; secondly, it shouldn't be "useful but annoying." For that latter category, Lowe says that automation is often the driving factor, and that signs of failure include lack of automation or poorly designed automation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.